ClinicalTrialsFinder

Chagas Cardiomyopathy Clinical Trials in São Paulo

1 recruitingSão Paulo, Brazil

Showing 1–1 of 1 trials

Recruiting
Phase 3

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

Chagas Cardiomyopathy
University of Sao Paulo General Hospital200 enrolled1 locationNCT04853758